Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Artificial Intelligence
From acquisition to advancement: How Medicus Pharma is shaping the future of medicine
Protalix Biotherapeutics is developing innovative treatments for rare diseases with its proprietary ProCellEx plant cell expression system
Zero Candida is revolutionizing yeast infection care with AI-driven blue-light therapy
Only registered members can use this feature.
or
Copyright © Proactive Group Holdings Inc, 2025
All Rights Reserved - Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.